Breath Metabolic Fingerprinting Lipid Screening Study
Summary
NCT07546162 is an observational clinical study registered on ClinicalTrials.gov evaluating non-invasive breath metabolic fingerprinting for large-scale population lipid screening. The study collects exhaled breath condensate samples from healthy and hyperlipidemic populations to analyze metabolic lipid profile characteristics and validate a new gas detection method for identifying abnormal blood lipids. The research aims to establish a simple, fast, and non-invasive approach for early detection of lipid abnormalities using mass spectrometry screening models.
“This study collects exhaled breath condensate samples from healthy populations and hyperlipidemic populations, analyzes the characteristics of the exhaled metabolic lipid profile for early identification of people with abnormal blood lipids, verifies the feasibility and accuracy of a new gas detection method for screening abnormal blood lipids, and explores a simple, fast, and non-invasive method for screening abnormal blood lipids.”
About this source
GovPing monitors ClinicalTrials.gov Studies for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 715 changes logged to date.
What changed
This is a ClinicalTrials.gov registration for NCT07546162, an observational study evaluating exhaled breath condensate analysis for lipid screening. The study will recruit healthy and hyperlipidemic populations to develop and validate a mass spectrometry-based screening model using breath metabolic fingerprinting. No compliance obligations are created by this registration. Researchers and healthcare institutions conducting or referring patients to clinical trials involving cardiovascular risk screening may find this study relevant to understanding emerging non-invasive diagnostic approaches.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Development and Clinical Validation of Key Technologies for Non-invasive Breath Metabolic Fingerprinting for Large-scale Population Lipid Screening
Observational NCT07546162 Kind: OBSERVATIONAL Apr 22, 2026
Abstract
This study collects exhaled breath condensate samples from healthy populations and hyperlipidemic populations, analyzes the characteristics of the exhaled metabolic lipid profile for early identification of people with abnormal blood lipids, verifies the feasibility and accuracy of a new gas detection method for screening abnormal blood lipids, and explores a simple, fast, and non-invasive method for screening abnormal blood lipids.
Conditions: Hyperlipidemia
Interventions: Lipid Abnormality Mass Spectrometry Screening Model
Mentioned entities
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.